Search
Bevacizumab Action Pathway
smpdb.ca/view/SMP0000420Drug actionBevacizumab is a humanized anti-VEGF monoclonal antibody used in the treatment of cancer. … Bevacizumab exerts its effect by binding to extracellular VEGF and preventing its binding to receptors on the endothelial cell surfaces.
Drugs: BevacizumabEnzymes: BevacizumabBevacizumab VEGF Inhibitor Action Pathway
smpdb.ca/view/SMP0122788Drug actionBevacizumab is a humanized monoclonal antibody administered intravenously to treat cancers such as colorectal cancer; non-small cell lung cancer; glioblastoma; hepatocellular cancer; renal cell carcinoma … Bevacizumab binds to VEGF in the blood and inactivates it, preventing its interaction with the VEGF receptors. The VEGF signaling pathway is not activated and angiogenesis does not occur.
Drugs: BevacizumabVEGF Signaling
smpdb.ca/view/SMP0524112SignalingInhibitors like Bevacizumab and Aflibercept block VEGF A, preventing its effects and inhibiting angiogenesis, making them useful in treating cancers and other diseases with abnormal blood vessel growth
Enzymes: Bevacizumab